معرفی
Professor Anthony Mathur is a leading academic and clinician at Queen Mary University of London's Faculty of Medicine and Dentistry, heading the Centre for Cardiovascular Medicine and Devices. His dual focus includes clinical work as Clinical Director for Interventional Cardiology at Barts Health and translational research in biologics (e.g., stem cells, gene therapy) and cardiovascular device innovation. He chairs key professional groups like the ESC Task Force on Stem Cells and leads the Cardiovascular Devices Hub (CVDHub), which bridges academia, industry, and clinical practice to develop novel devices. His research emphasizes first-in-man trials, digital technologies (e.g., avatars), and AI-driven solutions for cardiovascular care.
Research interests span stem cell therapy for heart failure/angina, advanced cardiac imaging (e.g., Cardiac CMR), and interventional cardiology techniques. He collaborates with institutions like Yale and UCL on clinical trials, including a Phase III study on cell therapy post-myocardial infarction. Key sponsors include the National Institute for Health and Care Research and British Heart Foundation.
Publications highlight contributions to coronary plaque analysis, device success algorithms, and hypertension risk stratification. His leadership roles and industry collaborations reflect a commitment to bridging research and clinical practice, with a focus on innovative treatments for unmet cardiovascular needs.
